These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 22489049)
21. Dextran, gelatin, and hydroxyethyl starch do not affect permeability for albumin in cat skeletal muscle. Holbeck S; Bentzer P; Wikstrand C; Grände PO Crit Care Med; 2001 Jan; 29(1):123-8. PubMed ID: 11176171 [TBL] [Abstract][Full Text] [Related]
22. Renal impact of fluid management with colloids: a comparative review. Davidson IJ Eur J Anaesthesiol; 2006 Sep; 23(9):721-38. PubMed ID: 16723059 [TBL] [Abstract][Full Text] [Related]
23. The effect of the type of colloid on the efficacy of hypertonic saline colloid mixtures in hemorrhagic shock: dextran versus hydroxyethyl starch. Strecker U; Dick W; Madjidi A; Ant M Resuscitation; 1993 Feb; 25(1):41-57. PubMed ID: 7680487 [TBL] [Abstract][Full Text] [Related]
24. Effect of mechanical factors on the function of engineered human blood microvessels in microfluidic collagen gels. Price GM; Wong KH; Truslow JG; Leung AD; Acharya C; Tien J Biomaterials; 2010 Aug; 31(24):6182-9. PubMed ID: 20537705 [TBL] [Abstract][Full Text] [Related]
25. Early hemodynamic and renal effects of hemorrhagic shock resuscitation with lactated Ringer's solution, hydroxyethyl starch, and hypertonic saline with or without 6% dextran-70. Nascimento P; de Paiva Filho O; de Carvalho LR; Braz JR J Surg Res; 2006 Nov; 136(1):98-105. PubMed ID: 16815449 [TBL] [Abstract][Full Text] [Related]
26. [The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl)]. Köhler H; Zschiedrich H; Clasen R; Linfante A; Gamm H Anaesthesist; 1982 Feb; 31(2):61-7. PubMed ID: 6177264 [TBL] [Abstract][Full Text] [Related]
27. Carbohydrate plasma expanders for passive tumor targeting: in vitro and in vivo studies. Hoffmann S; Caysa H; Kuntsche J; Kreideweiss P; Leimert A; Mueller T; Mäder K Carbohydr Polym; 2013 Jun; 95(1):404-13. PubMed ID: 23618286 [TBL] [Abstract][Full Text] [Related]
28. The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Neff TA; Fischler L; Mark M; Stocker R; Reinhart WH Anesth Analg; 2005 Jun; 100(6):1773-1780. PubMed ID: 15920212 [TBL] [Abstract][Full Text] [Related]
29. Effects on capillary fluid permeability and fluid exchange of albumin, dextran, gelatin, and hydroxyethyl starch in cat skeletal muscle. Holbeck S; Grände PO Crit Care Med; 2000 Apr; 28(4):1089-95. PubMed ID: 10809288 [TBL] [Abstract][Full Text] [Related]
30. Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspective. Martini J; Cabrales P; K A; Acharya SA; Intaglietta M; Tsai AG Crit Care; 2008; 12(2):R54. PubMed ID: 18423033 [TBL] [Abstract][Full Text] [Related]
31. PEG-albumin supraplasma expansion is due to increased vessel wall shear stress induced by blood viscosity shear thinning. Sriram K; Tsai AG; Cabrales P; Meng F; Acharya SA; Tartakovsky DM; Intaglietta M Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2489-97. PubMed ID: 22505638 [TBL] [Abstract][Full Text] [Related]
32. Glycocalyx degradation causes microvascular perfusion failure in the ex vivo perfused mouse lung: hydroxyethyl starch 130/0.4 pretreatment attenuates this response. Strunden MS; Bornscheuer A; Schuster A; Kiefmann R; Goetz AE; Heckel K Shock; 2012 Nov; 38(5):559-66. PubMed ID: 23042196 [TBL] [Abstract][Full Text] [Related]
33. A comparison of efficacy of dextran, oxypolygelatin, plasma and saline as plasma volume expanders. RAISZ LG; PULASKI EJ Am J Physiol; 1952 May; 169(2):475-82. PubMed ID: 14933615 [No Abstract] [Full Text] [Related]
34. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT. Konrad CJ; Markl TJ; Schuepfer GK; Schmeck J; Gerber HR Anesth Analg; 2000 Feb; 90(2):274-9. PubMed ID: 10648306 [TBL] [Abstract][Full Text] [Related]
35. [The effect of different volume expanders on neutrophil granulocyte function in vitro]. Welters ID; Spangenberg U; Menzebach A; Engel J; Menges T; Langefeld TW; Hempelmann G Anaesthesist; 2000 Mar; 49(3):196-201. PubMed ID: 10788988 [TBL] [Abstract][Full Text] [Related]
36. [Effects of plasma substitutes on hemostasis]. Blanloeil Y; Trossaërt M; Rigal JC; Rozec B Ann Fr Anesth Reanim; 2002 Oct; 21(8):648-67. PubMed ID: 12471786 [TBL] [Abstract][Full Text] [Related]
38. Use of plasma volume expanders in myocardial revascularisation. Lacy JH; Wright CB Drugs; 1992 Nov; 44(5):720-7. PubMed ID: 1280564 [TBL] [Abstract][Full Text] [Related]
39. An international view of hydroxyethyl starches. Treib J; Baron JF; Grauer MT; Strauss RG Intensive Care Med; 1999 Mar; 25(3):258-68. PubMed ID: 10229159 [TBL] [Abstract][Full Text] [Related]
40. A bioengineered array of 3D microvessels for vascular permeability assay. Lee H; Kim S; Chung M; Kim JH; Jeon NL Microvasc Res; 2014 Jan; 91():90-8. PubMed ID: 24333621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]